Search

for
Search:

Did you mean PPAR-gamma agonists?

GlossaryPPAR-gamma agonists

activate receptors to regulate glucose and lipid metabolism

PPAR-gamma agonists, also known as Peroxisome Proliferator-Activated Receptor Gamma agonists, are a class of drugs that activate the PPAR-γ receptor, a type of nuclear receptor involved in regulating genes related to glucose and lipid metabolism. These agonists are commonly used in the treatment of conditions like type 2 diabetes because they help improve insulin sensitivity and reduce blood sugar levels.

Related Terms

Research

5 / 1000+ results

research PPAR-γ Agonists and Their Role in Primary Cicatricial Alopecia

38 citations , January 2017 in “PPAR Research”

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

PPAR-γ Signaling as a Key Mediator of Human Hair Follicle Physiology and Pathology

research PPAR‐γ signalling as a key mediator of human hair follicle physiology and pathology

24 citations , November 2019 in “Experimental Dermatology”

PPAR-γ is important for healthy hair and its problems, and more research on PPAR-γ treatments is needed.

Peroxisome Proliferator Activated Receptors Gamma Serum Levels and Gene Polymorphism in Frontal Fibrosing Alopecia: A Case-Control Study

research Peroxisome Proliferator Activated Receptors Gamma Serum levels and Gene Polymorphism in Frontal Fibrosing Alopecia: A Case Control Study

July 2022 in “Research Square (Research Square)”

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

research The Pathogenesis of Primary Cicatricial Alopecias

150 citations , October 2010 in “The American Journal of Pathology”

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

research Syndecan-1 Is Required to Maintain Intradermal Fat and Prevent Cold Stress

88 citations , August 2014 in “PLOS genetics”

Syndecan-1 is essential for maintaining skin fat and preventing cold stress.

View more "ppar-gamma agonist" in research →

Community Join

5 / 16 results

community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

in Research 830 upvotes 2 years ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community You will lose hair if your prostaglandins aren't in balance

in Research/Science 56 upvotes 1 year ago

Prostaglandin balance affects hair loss, particularly in conditions like Lichen Planopilaris, where an imbalance can lead to hair follicle damage. Treatments mentioned include prostaglandin analogs and Pioglitazone HCL, with a focus on maintaining prostaglandin equilibrium for potential hair regrowth.

community The Worst Hair Loss Condition You (MAY) have: LPP

in Research/Science 52 upvotes 1 year ago

Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.

community Hair Loss & Lipids: Why you have sebderm, folliculitis, LPP, inflammation, etc...

in Research/Science 132 upvotes 1 year ago

Excess sebum rich in cholesterol and triglycerides can lead to hair loss through inflammation, with treatments like Ciclopirox shampoo, Benzoyl Peroxide shampoo, and Clindamycin gel recommended for managing conditions like seborrheic dermatitis and folliculitis. Pioglitazone is suggested for Lichen Planopilaris, while Omega-3s and reducing processed foods may improve sebum quality, though genetic factors play a significant role.

community If PP405 goes systemic this would be quite catastrophic

in Research/Science 4 upvotes 1 year ago

Concerns about the potential systemic effects and safety of PP405 for hair loss, with discussions on its comparison to existing treatments like finasteride and minoxidil. Users express skepticism about untested research chemicals and emphasize the importance of clinical trials to ensure safety and efficacy.

View more "ppar-gamma agonist" in community →